Immunogenomic profiling and pathological response results from a clinical trial of docetaxel and carboplatin in triple-negative breast cancer.

Foluso O AdemuyiwaIna ChenJingqin LuoMothaffar F RimawiIan S HagemannBryan FiskGejae JeffersZachary L SkidmoreAnamika BasuMegan RichtersCynthia X MaKatherine WeilbaecherJennifer DavisRama SureshLindsay L PetersonRon BoseNusayba BagegniCaron E RigdenAshley FrithTimothy P ReardenLeonel F Hernandez-AyaAnna RoshalKatherine CliftonMateusz OpyrchalOlaronke Akintola-OgunremiByung Ha LeeSara Ferrando-MartinezSarah E ChurchMeenakshi AnuragMatthew J EllisFeng GaoWilliam GillandersObi L GriffithMalachi Griffith

Published in: Breast cancer research and treatment (2021)

Clinical trial information: NCT02124902, Registered 24 April 2014 & NCT02547987, Registered 10 September 2015.

Keyphrases

clinical trial
phase iii
phase ii
open label
double blind
study protocol
phase ii study
healthcare